Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Antigen of inactivated whole Rabies lyssavirus Flury LEP strain grown in cellular line (substance) | est un(e) (attribut) | Inactivated whole Rabies lyssavirus antigen | false | Inferred relationship | Some | ||
Antigen of inactivated whole Rabies lyssavirus Flury LEP strain grown in cellular line (substance) | est un(e) (attribut) | Antigen of inactivated whole Rabies lyssavirus grown in cellular line (substance) | true | Inferred relationship | Some | ||
Antigen of inactivated whole Rabies lyssavirus Flury LEP strain grown in cellular line (substance) | est un(e) (attribut) | Antigen of inactivated whole Rabies lyssavirus grown in cellular line (substance) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
RabAvert 2.5 international units per milliliter powder for solution for injection Novartis Vaccines and Diagnostics Gmbh (real clinical drug) | a pour principe actif (attribut) | True | Antigen of inactivated whole Rabies lyssavirus Flury LEP strain grown in cellular line (substance) | Inferred relationship | Some | 1 |
RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | True | Antigen of inactivated whole Rabies lyssavirus Flury LEP strain grown in cellular line (substance) | Inferred relationship | Some | 1 |
RABAVERT 2.5 international units per milliliter powder for solution for injection Bavarian Nordic A/S (real clinical drug) | a pour principe actif (attribut) | True | Antigen of inactivated whole Rabies lyssavirus Flury LEP strain grown in cellular line (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets